Gene Therapy Latest News | Experimental Gene Therapy Studies

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

06 August 2020

Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress

12 July 2020

Gene Therapy BAY 2599023 Showing Steady FVIII Activity, Safety in Trial

24 July 2020

Freeline Raises $120M for Pivotal Trial of FLT180a, a Gene Therapy Candidate for Hemophilia B

10 July 2020

Investigational Gene Therapy Results in Huge Drop in Bleeding Rates and Factor VIII Usage, Updated Data Show
24 June 2020
Efficacy of Gene Therapy SB-525 Now at 14 Months in Alta Hemophilia A Trial
19 June 2020
BioMarin’s Gene Therapy for Hemophilia A Continues to Prevent Bleeds After Four Years, Trial Shows
03 June 2020
FDA Agrees to Phase 1 Trial of ET3, Gene Therapy for Hemophilia A
27 May 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL